This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Long-term sevelamer treatment lowers serum fibrobl...
Journal

Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.

Read time: 1 mins
Published:25th Mar 2020
Author: Lin HH, Liou HH, Wu MS, Lin CY, Huang CC.
Source: Nephrology
Ref.:Nephrology (Carlton). 2014 Nov;19(11):672-8.
DOI:10.1111/nep.12319.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest